Covid vaccines may cause period problems, experts warn / Photo: John MACDOUGALL - AFP/File
-
Physicians Urge Arizona to Ban Medical Gag Clauses and Enable Private Lawsuits
-
China Extends Tariff Suspension on US Imports to Stabilize Trade Ties
-
New Campaign Highlights Knowledge Gaps on Carbon Monoxide Safety Among Americans
-
JR East Launches 'teppay' to Integrate Suica Balance with Mobile Payments
-
GoodData.AI Launches the Agentic Serving Plane, a New Category of Enterprise Data Infrastructure for AI Agents
-
Securitas Healthcare Introduces a New Era of RTLS Built for the Future of Healthcare Operations
-
US Government Questions Effectiveness of Waymo’s School Bus Software Fix
-
First-time boat buyers advised to assess full ownership costs
-
Panthers expected to begin 2027 NRL season away from new stadium
-
Planning and preparation can reduce stress of interstate relocation
-
Sweet As app launches restaurant discovery platform
-
Two more arrested in Carrie Mullane suspected murder investigation
-
MLA seeks inquiry into reported sectarian gestures on Ormeau Road
-
Mayo school appeals for information after convent and chapel vandalism
-
Louise O’Reilly attacks Simon Harris over unemployment remarks
Covid vaccines may cause period problems, experts warn
Some Covid vaccines may cause heavy menstrual bleeding, specialists at the European Medicines Agency (EMA) warned Friday, recommending that this be added to the list of potential side-effects.
"Cases of heavy menstrual bleeding have been reported after the first, second and booster doses of Comirnaty (Pfizer) and Spikevax (Moderna)," said a statement from the agency, citing its drugs safety committee.
Having reviewed the data, they concluded that "there is at least a reasonable possibility that the occurrence of heavy menstrual bleeding is causally associated with these vaccines".
They thus recommended that this be added to the product information of the two mRNA Covid-19 vaccines.
"There is no evidence to suggest the menstrual disorders experienced by some people have any impact on reproduction and fertility," the EMA statement added.
The safety committee also stressed that "the benefits of these vaccines greatly outweigh the risks".
The instances of heavy menstrual bleeding have been monitored at both national and European level since the first reports appeared among vaccinated women.
France's National Medicine Safety Agency (ANSM) started interviewing women about the issue in July, passing their findings to the EMA.
So far, however, researchers have not established a causal connection beyond any doubt.
The reported issues mainly concern changes to the length and intensity of the menstrual bleeding, which are sometimes more painful.
While in most cases the symptoms experienced were "not serious" and transitory, some women experienced the symptoms for up to six months, the ANSM reported.
The French agency is continuing to research the issue.
Ferreira--PC
